Bank of America Corp DE Raises Stock Position in Lumexa Imaging Holdings, Inc. $LMRI

Key Points

• Bank of America sharply increased its Lumexa Imaging stake during the first quarter, adding 111,307 shares to own 111,313 shares valued at approximately $957,000, or 0.12% of the company.
• Analyst sentiment is generally positive: Lumexa has a “Moderate Buy” consensus rating and a $17.33 average price target, with Barclays recently raising its target to $13 from $9.
• Lumexa reported quarterly EPS of $0.20, exceeding the $0.03 consensus estimate, on revenue of $264.16 million. Its shares opened at $12.18, while the company provided fiscal 2026 EPS guidance of $0.71 to $0.77.

Bank of America Corp DE lifted its holdings in shares of Lumexa Imaging Holdings, Inc. (NASDAQ:LMRI - Free Report) by 1,855,116.7% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 111,313 shares of the company's stock after acquiring an additional 111,307 shares during the quarter. Bank of America Corp DE owned about 0.12% of Lumexa Imaging worth $957,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also recently added to or reduced their stakes in LMRI. Strs Ohio acquired a new position in shares of Lumexa Imaging during the first quarter worth about $38,000. PNC Financial Services Group Inc. acquired a new stake in shares of Lumexa Imaging in the first quarter valued at about $63,000. State of Wyoming purchased a new stake in shares of Lumexa Imaging during the 1st quarter valued at about $91,000. Barclays PLC acquired a new position in Lumexa Imaging during the 4th quarter worth approximately $133,000. Finally, Sandia Investment Management LP purchased a new position in Lumexa Imaging in the 4th quarter worth approximately $185,000.

Wall Street Analyst Weigh In

LMRI has been the topic of a number of analyst reports. Wall Street Zen upgraded shares of Lumexa Imaging from a "hold" rating to a "buy" rating in a research note on Sunday, August 16th. Barclays raised their price target on shares of Lumexa Imaging from $9.00 to $13.00 and gave the company an "overweight" rating in a report on Friday, August 28th. Weiss Ratings upgraded shares of Lumexa Imaging from a "sell (e)" rating to a "sell (d)" rating in a report on Thursday, June 25th. Finally, Deutsche Bank Aktiengesellschaft set a $16.00 target price on Lumexa Imaging in a research report on Thursday, August 13th. One research analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $17.33.

Lumexa Imaging Price Performance

Shares of LMRI stock opened at $12.18 on Friday. The firm has a fifty day moving average of $11.56 and a two-hundred day moving average of $10.83. The firm has a market cap of $1.17 billion and a P/E ratio of -24.86. Lumexa Imaging Holdings, Inc. has a 1-year low of $6.45 and a 1-year high of $19.45. The company has a debt-to-equity ratio of 1.40, a current ratio of 1.44 and a quick ratio of 1.44.

Lumexa Imaging (NASDAQ:LMRI - Get Free Report) last issued its quarterly earnings results on Wednesday, August 12th. The company reported $0.20 EPS for the quarter, topping the consensus estimate of $0.03 by $0.17. The company had revenue of $264.16 million for the quarter. Lumexa Imaging has set its FY 2026 guidance at 0.710-0.770 EPS. As a group, research analysts anticipate that Lumexa Imaging Holdings, Inc. will post 0.25 earnings per share for the current fiscal year.

Lumexa Imaging Company Profile

We are one of the largest national providers of diagnostic imaging services(1). Our platform is integrated, scalable and has a proven track record of creating value for our stakeholders. As of September 30, 2025, we and our affiliates operated the second largest(1) outpatient imaging center footprint in the United States. It spans 184 centers(2)across 13 states and includes eight joint venture partnerships with health systems. Our centers are in attractive metropolitan statistical areas (“MSAs”).

Want to see what other hedge funds are holding LMRI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lumexa Imaging Holdings, Inc. (NASDAQ:LMRI - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source